(Q40402176)

20 September 2017

title

Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases (English)

1 reference

20 September 2017

1 reference

Allen D Brinker

1

1 reference

20 September 2017

Ronald T Wassel

2

1 reference

20 September 2017

Jenna Lyndly

3

1 reference

20 September 2017

Jose Serrano

4

1 reference

20 September 2017

Mark Avigan

5

1 reference

20 September 2017

William M Lee

6

1 reference

20 September 2017

Leonard B Seeff

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

20 September 2017

1 reference

20 September 2017

volume

49

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

250-257

1 reference

Hepatotoxicity of antimicrobial agents

20 September 2017

cites work

1 reference

Outcome and prognostic markers in severe drug-induced liver disease

21 January 2018

1 reference

Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review

21 January 2018

1 reference

Acute hepatitis attack after exposure to telithromycin

21 January 2018

1 reference

Elevated hepatic transaminases associated with telithromycin therapy: a case report and literature review

21 January 2018

1 reference

Drug-induced liver injury: summary of a single topic clinical research conference

21 January 2018

1 reference

Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct

21 January 2018

1 reference

Drug-induced liver injury: Hy's rule revisited

21 January 2018

1 reference

Limitations and strengths of spontaneous reports data

21 January 2018

1 reference

Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting.

21 January 2018

1 reference

Idiosyncratic drug reactions: current understanding

21 January 2018

1 reference

An official ATS statement: hepatotoxicity of antituberculosis therapy

21 January 2018

1 reference

Troglitazone-induced liver failure: a case study

21 January 2018

1 reference

Possible gatifloxacin-induced fulminant hepatic failure

21 January 2018

1 reference

Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain.

21 January 2018

1 reference

Fulminant hepatitis and fatal toxic epidermal necrolysis (Lyell disease) coincident with clarithromycin administration in an alcoholic patient receiving disulfiram therapy

21 January 2018

1 reference

Fulminant liver failure associated with clarithromycin

21 January 2018

1 reference

Tissue kinetics of telithromycin, the first ketolide antibacterial

21 January 2018

1 reference

Antibiotic drug interactions

21 January 2018

1 reference

Telithromycin: the first ketolide antimicrobial

21 January 2018

1 reference

Apparent anaphylactoid reaction after treatment with a single dose of telithromycin

21 January 2018

1 reference

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

21 January 2018

1 reference

Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury

21 January 2018

1 reference

Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period

21 January 2018

1 reference

7 January 2021

Use of a spontaneous adverse drug events database for identification of unanticipated drug benefits

1 reference

7 January 2021

Drug-induced liver injury network (DILIN)

1 reference

7 January 2021

Fulminant hepatic failure associated with intravenous erythromycin lactobionate

1 reference

7 January 2021

Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines

1 reference

7 January 2021

Myasthenia gravis exacerbation or unmasking associated with telithromycin treatment

1 reference

7 January 2021

Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22620

1 reference

20 September 2017

1 reference